SCYX 240816 2.50C (SCYX240816C2500) Stock Options, News & Quotes

US OptionsDetailed Quotes

SCYX240816C2500

Watchlist

0.20
0.000.00%

15min DelayTrading Jul 23 15:09 ET

0.00High0.00Low

Intraday

5D
Daily

News

Express News | Scynexis Inc - Cash Runway Exceeds Two Years
ReutersJul 23 07:04 ET
Express News | Scynexis : GSK Will Also Pay Mid-Single Digit to Mid-Teen Digit Tiered Royalties on Totality of Ibrexafungerp Sales Across All Indications
ReutersJul 23 07:04 ET
Express News | Scynexis Inc - Milestone Payment Triggered by Clinical Study Reports
ReutersJul 23 07:03 ET
Express News | Scynexis : Eligible for Additional $323 Million in Milestone Payments
ReutersJul 23 07:02 ET
Express News | Scynexis to Receive $10 Million Milestone Payment From GSK Triggered by Delivery of Completed Furi, Cares and Nature Clinical Study Reports
ReutersJul 23 07:00 ET
Buy Rating Affirmed for Scynexis on Robust Financials and Promising Antifungal Pipeline
TipRanksMay 10 12:15 ET

Comments

Trytosaveabit

Yesterday 19:01

Update

$Scynexis(SCYX.US)$ Reuters· just
Scynexis to Receive $10 Million Milestone Payment From GSK Triggered by Delivery of Completed Furi, Cares and Nature Clinical Study Reports

ForeverBean

Jul 16 11:00

$Scynexis(SCYX.US)$ not making money. Why people buying I suggest we just let it fall.

ForeverBean

Jul 11 14:06

$Scynexis(SCYX.US)$ Any good news? No, just some usual and insignificant fluctuations.

ForeverBean

Jul 5 14:47

$Scynexis(SCYX.US)$ More to hold

ForeverBean

Jun 20 15:48

$Scynexis(SCYX.US)$ I would very much like to be informed of more progress in their dealing with the ibrexafungerp cross contamination issue. Couldn't find anything useful nonetheless.